ClinicalTrials.gg
Sign In

Postpartum Hemorrhage clinical trials

The registry lists 469 studies for Postpartum Hemorrhage across more than 10 countries. 76 are recruiting or about to start. 419 of them are mainly about Postpartum Hemorrhage (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Postpartum Hemorrhage studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
297
Status unknown
63
Recruiting
42
Not yet recruiting
33
Terminated
15
Withdrawn
12

Phase

Phase 4
60
Phase 3
52
Phase 2
34
Phase 1
15
Early Phase 1
8

Where

Egypt
75
United States
65
Canada
43
Turkey
43
France
28
Pakistan
17

Who runs them

Samuel Lunenfeld Research Institute, Mount Sinai Hospital (34) · Gynuity Health Projects (23) · Cairo University (20) · Assiut University (15) · Aswan University Hospital (12) · Stanford University (7) · Assistance Publique - Hôpitaux de Paris (6) · Ain Shams University (6)

What is being tested here

Drugs under test in Postpartum Hemorrhage studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Oxytocin9864
Tranexamic Acid81849
Misoprostol21359
Carbetocin2644
Calcium Chloride213
Ergonovine126
Carboprost104
Calcium Gluconate102
Aspirin112
Recombinant FVIIa102

Drug classes tested here NSAIDs 1 open

Coming up

9phase 3 studies under way
34studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 42 Postpartum Hemorrhage studies recruiting now, 21 (50%) set no upper age limit and 21 (50%) stop at 75 or younger. 6 (14%) take children under 18. 39 (93%) are for women only and 1 (2%) for men only; 21 (50%) take healthy volunteers.

Recruiting studies that take each age, of 42
AgeWomenMen
105 (12%)1 (2%)
1838 (90%)2 (5%)
3041 (98%)3 (7%)
4040 (95%)3 (7%)
5030 (71%)3 (7%)
6521 (50%)3 (7%)
7520 (48%)3 (7%)
8520 (48%)3 (7%)

Across all 469 studies, recruiting or not: 58% stop at 75 or younger and 57% at 65; 25% take children; 92% are for women only and <1% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Postpartum Hemorrhage studies take

Of 28 phase 4 interventional studies under Postpartum Hemorrhage, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 318 mo9–38 · 20 studies——
Phase 412 mo10–20 · 28 studies—12 mo10–20 · 27 studies
Interventional, no phase16 mo7–26 · 119 studies—16 mo7–26 · 112 studies
Observational21 mo9–38 · 42 studies—30 mo10–39 · 38 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 469. Browse all 469 → or search them.